U.S. market Closed. Opens in 1 hour 42 minutes

MTLS | Materialise NV Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 6.76 - 7.19
52 Week Range 4.70 - 7.56
Beta 0.98
Implied Volatility 86.42%
IV Rank 14.48%
Day's Volume 185,265
Average Volume 176,744
Shares Outstanding 59,067,186
Market Cap 420,558,364
Sector Technology
Industry Software - Application
IPO Date 2014-06-25
Valuation
Profitability
Growth
Health
P/E Ratio 39.56
Forward P/E Ratio N/A
EPS 0.18
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 2,437
Country Belgium
Website MTLS
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
MTLS's peers: MIXT, CCRD, ADEA, LAW, AMSWA, MLNK, MODN, MNTV, PWSC, CWAN, EXFY, ENV, ENFN, VTEX, ONTF, ONVO
*Chart delayed
Analyzing fundamentals for MTLS we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is very poor, Growth is very bad and Health is passable. For more detailed analysis please see MTLS Fundamentals page.

Watching at MTLS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on MTLS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙